The Latest Breaking News from BDX

Becton, Dickinson (NYSE:BDX) has outperformed the market over the past 20 years by 3.34% on an annualized basis producing an average annual return of 10.37%. Currently, Becton, Dickinson has a market capitalization of $71.95 billion.

Becton Dickinson and Co (NYSE:BDX) will acquire Parata Systems from Frazier Healthcare Partners for $1.525 billion.  Parata offers a portfolio of pharmacy automation solutions to reduce costs, enhance patient safety and improve the patient experience.  Significant macro trends such as clinician shortages, wage inflation, centralization of pharmacy services, and increased clinical demands…

Becton, Dickinson (NYSE:BDX) has outperformed the market over the past 10 years by 1.48% on an annualized basis producing an average annual return of 13.59%. Currently, Becton, Dickinson has a market capitalization of $72.68 billion.

Growing demand for critical surgical procedures and increasing investments in R&D should drive the medical devices industry’s growth. Prominent medical device companies Becton Dickinson (BDX) and Intuitive Surgical (ISRG) are well-positioned to capitalize on the industry tailwinds. But which of these stocks is a better buy now? Read more to…

The stock market has witnessed a massive sell-off lately on concerns over the Fed’s aggressive interest rate hikes to fight the decade-high inflation. Many analysts expect the economy to slip into recession due to the Fed’s monetary policy tightening. Since the medical device industry is known to be one of…

Becton Dickinson and Co (NYSE:BDX) reported Q2 FY22 revenues of $5.01 billion, up 2.1% Y/Y (3.9% on a currency-neutral basis), better than the consensus of $4.85 billion. Revenue was driven by base revenue growth of 8.2% as reported, 10.2% currency-neutral, partially offset by the decline in COVID-only testing revenues to $214 million…

Deepening logistical disruptions caused by the Russia-Ukraine war, record-high inflation, and high oil prices have dampened investor sentiment. Furthermore, many economists expect the economy to succumb to a recession, with inflation hitting a fresh 40-year high and oil prices soaring. Therefore, we think it could be wise to bet on…

Defensive stocks are known for exhibiting stability during wild price swings in the market. And growing sanctions on Russia and the unstable nature of crude oil prices may drive further volatility in the market. So, we think it could be wise to bet now on defensive stocks CVS Health (CVS),…

Because concerns over high inflation and increasing sanctions on Russia are expected to fuel stock market volatility in the near term, we think it could be wise to bet on dividend aristocrats Johnson & Johnson (JNJ), Procter & Gamble (PG), PepsiCo (PEP), Abbott (ABT), and Becton Dickinson (BDX) for a…

Investing in fundamentally sound value stocks could be ideal amid surging market volatility, which is due to the rising interest rates, heightened inflation, supply chain disruptions, and an escalating war between Russia and Ukraine. Thus, we think the shares of industry leaders Bristol-Myers (BMY), Lockheed Martin (LMT), Becton Dickinson (BDX),…

Becton Dickinson and Co (NYSE: BDX) reported Q1 FY22 revenues of $4.9 billion, down 6% Y/Y (-5.9% on a currency-neutral basis), better than the consensus of $4.76 billion.